drugset / Trial / NCT02503865

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

NCT02503865 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

Timeline

Start
2003-01
Primary completion
2008-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg —
Comparator Diltiazem Small molecule 90 mg —
Comparator Lizinopril Unknown 20 mg —
Comparator Orlistat Small molecule 120 mg —
Comparator Pioglitazone Small molecule 30 mg —

Indications